The Braves and the Unsung Heroes
The Pharmaceutical Companies are evil, greedy, cold-hearted, sneaky, clandestine, and rotten. They don’t care about anything other than the bottom-line. Nothing good ever comes out of the pharma companies. They are responsible for most of what’s wrong with the healthcare of the society.
What do you say to people who think “Big Pharma” is hiding a cure for cancer from us?
There’s this brilliant scientist, Dr. Jennifer McFly, who leads a team of other brilliant people working out of East Snow Dump, Massachusetts site of the Big Pharma company. These people are very smart. I mean they were glasses, lab coats, know how to use pipettes, can
Are diseases deliberately spread as experiments for the pharmaceutical industry?
This type of questions get asked a lot, aren’t they? Here’s my answer which I’d posted on Quora. Yes. It is true. As a matter of fact, it has happened in the past and we have 123 minutes video evidence of how the whole
Cost of Developing a New Drug
When you google “cost of developing a new drug”, you get over 197,000,000 results. Some of the top search results are from Scientific American, Forbes, JAMA, Policy& Medicine, Wikipedia,and New England Journal of Medicine, among others. In the images section, you mostly get a bunch of graphs and tables. Youtube also gives an
The Myths about the Pharmaceutical Industry
The word “myth” is defined in the dictionary as “a widely held but false belief or idea.” In other words it’s a lie that everybody treats as truth. The validity of the statement is accepted even if it’s not true. Then the statement
The Pharma Do Cure – Many Diseases, Permanently!
“I’m telling you, the pharma companies make money by treating a disease, not curing.” How many times have we heard the above or some sort of variation of the above from family, friends, and comedians? For the record, that stopped being funny a long time
Episode 9 – Prof Charles Cooney, the History and Future of Biotech and Boston Ballet
My guest today is Prof Charles Cooney. Prof Cooney received his B.S. in chemical engineering from the University of Pennsylvania in 1966, and the S.M. (1967) and Ph.D. (1970) in biochemical engineering from MIT. He joined the MIT faculty as an assistant professor
Episode 8 – David Sullivan on New Modalities, Price, Patients and the Pharma Landscape
My guest today is David Sullivan, Sr. Director and Global Lead of Vaccines and Biologics MSAT at Pfizer. He did his Bachelor’s in Biotechnology from Worcester Polytechnic Institute and Master’s in Engineering Management from Tufts University. Over the years, he’s worked in process
Episode 7 – Salvatore Mascia and Continuous Manufacturing
My guest today is Salvatore Mascia. Sal is the Co-Founder & CEO of CONTINUUS Pharmaceuticals based in Woburn, MA. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end continuous
Episode 6 – Matt Roberge and the Global Pharma Forces
My guest today is Matt Roberge. He got his Mechanical Engineering degree from Villanova Uni. He currently works for Pfizer and serves as a senior director of Global technology network and Emerging market. He has a truly global organization with teams in the